Clinical Trials Browser

INDUSTRY × Interventional × TAK-243 × Clear all

NCT02045095 2019-03-14

A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors

Phase 1 Terminated

29 enrolled 25 charts

Other solid neoplasm

Advanced Malignant Solid Tumors